VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW
posted
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that its Irvine, CA based CLIA certified and College of American Pathologists (CAP) accredited laboratory has received a certification of conformity to ISO 9001:2008 from DEKRA Certification, Inc., Chalfont, PA. read more
TiGenix (Euronext Brussels: TIG), a leader in the field of cell therapy, announced today that further to the cGMP inspection by the Spanish health authorities it has successfully renewed its manufacturing authorization for stem cell products at its manufacturing facility in Madrid, Spain. read more
reMYND NV has received a positive ruling from the Belgian Tax Authorities. The ruling stipulates that the upfront license fee, all milestone payments and royalties linked to Roche Basel will qualify for the patent income deduction under Articles 205 WIB 92. read more
Ablynx [Euronext Brussels: ABLX] today announced that it has been granted another key European patent around its Nanobody®-based half-life extension technology. The decision to grant the European patent EP 1 888 641 was issued by the European Patent Office on November 17, 2011. read more
Cryo-Save Switzerland was positively reviewed by Swissmedic, Switzerland’s government agency for therapeutic products. The received accreditation confirms Cryo-Save’s continuous efforts to deliver high quality, and safe and effective procedures while collecting, processing and preserving stem cells from umbilical cord and cord blood. read more
